Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PRECISION BIOSCIENCES INCDTIL · Entity 6284 | General Counsel and Secretary | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PRECISION BIOSCIENCES INC
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 107,604 |
Reported balance
After 2026-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 107,604 · Balance 107,604 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 16:06 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 107,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040220 · wk-form4_1780517173.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,604 Underlying: Common Stock · 107,604 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on February 18, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 18, 2026 Filed Feb 19, 2026 16:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 4,925 | $3.84 | $18,912.00 |
DisclosureSEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,457 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 16:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: RSUs vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 16:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 16,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-009802 · wk-form4_1771536649.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on February 17, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 21, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 8,854 | $4.03 | $35,681.62 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,715 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 14,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 7 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,907 Underlying: Common Stock · 14,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 6 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,425 Underlying: Common Stock · 8,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 1,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · derivative · entry 5 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,978 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vested in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 14,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 8,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 18:48 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 1,978 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-003148 · wk-form4_1769125727.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on January 20, 2026. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 665 | $6.49 | $4,315.85 |
DisclosureSEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,258 F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 29, 2025. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| November 02, 2025 Filed Nov 4, 2025 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 1,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,835 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025. F5 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on November 2, 2025. Read SEC document |
| November 02, 2025 Filed Nov 4, 2025 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 1,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-048856 · wk-form4_1762290934.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: Includes 2,088 shares acquired under the Issuer's 2019 Employee Stock Purchase Plan at a weighted average price of $4.26. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 17:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081722 · ownership.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 19:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 272 | $4.91 | $1,335.52 |
DisclosureSEC source: 0000950170-25-034016 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 919 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-034016 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 919 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025 F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on March 3, 2025 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 19:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 919 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-034016 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,272 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on March 3, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| January 22, 2025 Filed Jan 22, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 8,928 | $4.79 | $42,765.12 |
DisclosureSEC source: 0000950170-25-008014 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,353 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 20, 2025 Filed Jan 22, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 14,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 5 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,815 Underlying: Common Stock · 14,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On August 22, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2025 Filed Jan 22, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 8,427 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,850 Underlying: Common Stock · 8,427 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On April 18, 2024 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2025 Filed Jan 22, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 1,977 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008014 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,978 Underlying: Common Stock · 1,977 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2025 Filed Jan 22, 2025 21:00 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 25,312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-008014 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2025. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| November 04, 2024 Filed Nov 5, 2024 19:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 588 | $8.19 | $4,815.72 |
DisclosureSEC source: 0000950170-24-121727 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,969 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| November 02, 2024 Filed Nov 5, 2024 19:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-121727 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,835 Underlying: Common Stock · 1,836 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2024 Filed Nov 5, 2024 19:14 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 1,836 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-121727 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 07:30 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 44,723 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-100018 · ownership.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,723 Underlying: Common Stock · 44,723 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 17:13 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 93 | $11.79 | $1,096.47 |
DisclosureSEC source: 0000950170-24-072052 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,721 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.70 to $12.00. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 17:13 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072052 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. The RSUs vested in full on June 7, 2024. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 17:13 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 301 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-072052 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 08, 2024 Filed May 8, 2024 20:25 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantCommon Stock | 833 | $12.00 | $9,996.00 |
DisclosureSEC source: 0000950170-24-056138 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,513 F1 · shares: Represents shares purchased through a definitive subscription agreement, pursuant to which the Issuer agreed to issue and sell shares of its common stock in a non-brokered private placement to certain members of its management. Read SEC document |
| May 02, 2024 Filed May 3, 2024 18:33 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 272 | $10.32 | $2,807.04 |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,680 F4 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:33 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleRestricted Stock Units · Derivative | 918 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 919 Underlying: Common Stock · 918 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F6 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F6 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| May 01, 2024 Filed May 3, 2024 18:33 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-053115 · ownership.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. F2 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F3 · balance_after: On February 13, 2024, the Issuer effected a 1-for-30 reverse stock split. The amounts of securities herein have been adjusted to reflect the reverse stock split. Read SEC document |
| April 18, 2024 Filed Apr 22, 2024 21:12 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantRestricted Stock Units · Derivative | 25,277 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-046597 · ownership.xml · derivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,277 Underlying: Common Stock · 25,277 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: Award vests in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 19:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 21,287 | $0.36 | $7,663.32 |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,028 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees. Read SEC document |
| January 20, 2024 Filed Jan 23, 2024 19:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 59,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,655 Underlying: Common Stock · 59,345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| January 20, 2024 Filed Jan 23, 2024 19:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 59,345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-24-002117 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| November 03, 2023 Filed Nov 6, 2023 17:09 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 16,023 | $0.40 | $6,409.20 |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,970 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. F3 · shares: The sales were effected pursuant to a Rule 10b5-1 plan adopted on July 14, 2023. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 17:09 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 55,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · derivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,123 Underlying: Common Stock · 55,077 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| November 02, 2023 Filed Nov 6, 2023 17:09 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 55,077 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-054552 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on November 2, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 16:16 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | GrantCommon Stock | 5,443 | $0.39 | $2,122.77 |
DisclosureSEC source: 0001209191-23-048150 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,916 F1 · kind: These shares were acquired under the Issuer's 2019 Employee Stock Purchase Plan subsequent to the Reporting Person's Form 4 filed on June 9, 2023. Read SEC document |
| June 08, 2023 Filed Jun 9, 2023 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 13,361 | $0.75 | $10,020.75 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,473 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 9,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 5 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,045 Underlying: Common Stock · 9,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F5 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F5 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,727 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. F4 · derivative.exercise_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On June 7, 2021 the Reporting Person was granted RSUs, which vest in two equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 9,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:15 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 22,727 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035789 · doc4.xml · nonDerivative · entry 1 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on June 7, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 17:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | SaleCommon Stock | 12,172 | $1.07 | $13,024.04 |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 3 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,063 F3 · kind: The sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 17:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionRestricted Stock Units · Derivative | 27,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · derivative · entry 4 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,101 Underlying: Common Stock · 27,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F4 · derivative.expiration_date: On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 17:19 UTC | PRECISION BIOSCIENCES INC DTIL · Entity 6284 | Exercise / conversionCommon Stock | 27,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-016866 · doc4.xml · nonDerivative · entry 2 Scimeca Dario · CIK 0001779581 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on March 3, 2023. F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.